EUVIMEDEUVIMED entdecken
Crossref

In Vitro and In Silico Evaluation of ACE2 and LOX Inhibitory Activity of Origanum Essential Oils and Carvacrol

Fatih Demirci iD, Kerem Teralı iD, Ayşe Esra Karadağ iD, Sevde Nur Biltekin iD, Ezgi Ak Sakallı iD, Betül Demirci iD, Müberra Koşar iD, K Hüsnü Can Başer iD

Planta Medica · 01.07.2023 · 89 (08) · 790-799

DOI: 10.1055/a-1828-2479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.07.2023. Verfasst von Fatih Demirci und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey. Hauptthemen laut MEDLINE: Oils, Volatile, Origanum. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Anadolu University Scientific Research Projects Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Origanum spp. are used both for culinary purposes and for their biological activities. In this study, commercial Origanum majorana, Origanum minutiflorum, Origanum vulgare, and Origanum onites essential oils and their prominent constituent carvacrol were evaluated for their in vitro and in silico angiotensin-converting enzyme 2 and lipoxygenase enzyme inhibitory potentials. The essential oils were analysed by gas chromatography-flame ionisation detection and gas chromatography-mass spectrometry, where carvacrol was identified as the major component (62 – 81%), confirming the quality. In vitro enzyme inhibition assays were conducted both with the essential oils (20 µg/mL) and with carvacrol (5 µg/mL). The comparative values of angiotensin-converting enzyme 2 percent inhibition for O. majorana, O. minutiflorum, O. vulgare, and O. onites essential oils were determined as 85.5, 79.1, 74.3, and 42.8%, respectively. As a result of the enzyme assays, carvacrol showed 90.7% in vitro angiotensin-converting enzyme 2 inhibitory activity. The in vitro lipoxygenase inhibition of the essential oils (in the same order) was 89.4, 78.9, 81.1, and 73.5%, respectively, where carvacrol showed 74.8% inhibition. In addition, protein–ligand docking and interaction profiling was used to gain structural and mechanistic insights into the angiotensin-converting enzyme 2 and lipoxygenase inhibitory potentials of major Origanum essential oil constituents. The in silico findings agreed with the significant enzyme inhibition activity observed in vitro. Further in vivo studies are suggested to confirm the safety and efficacy of the oils.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oils, VolatileOriganumAngiotensin-Converting Enzyme 2LipoxygenasesHumansCymenes

Substanzen

Angiotensin-Converting Enzyme 2LipoxygenasesOils, VolatilecarvacrolCymenes

Autor:innen und Institutionen

  • Department of Pharmacognosy, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
  • Faculty of Pharmacy, Eastern Mediterranean University, Famagusta, N. Cyprus, Mersin 10, Turkey.
  • Department of Medical Biochemistry, Faculty of Medicine, Girne American University, Kyrenia, Mersin 10, Turkey.
  • Department of Pharmacognosy, School of Pharmacy, Istanbul Medipol University, Beykoz, Istanbul, Turkey.
  • Graduate School of Health Sciences, Anadolu University, Eskişehir, Turkey.
  • Department of Pharmaceutical Microbiology, School of Pharmacy, Istanbul Medipol University, Beykoz, Istanbul, Turkey.

ORCID-Profile: Fatih Demirci, Kerem Teralı, Ayşe Esra Karadağ, Sevde Nur Biltekin, Ezgi Ak Sakallı, Betül Demirci, Müberra Koşar, K Hüsnü Can Başer

Förderung

  • Anadolu University Scientific Research Projects Commission

Zitieren

APA

Demirci, F., Teralı, K., Karadağ, A. E., Biltekin, S. N., Ak Sakallı, E., Demirci, B., Koşar, M., & Başer, K. H. C. (2023). In Vitro and In Silico Evaluation of ACE2 and LOX Inhibitory Activity of Origanum Essential Oils and Carvacrol. Planta Medica, 89(08), 790-799. https://doi.org/10.1055/a-1828-2479

Vancouver

Demirci F, Teralı K, Karadağ AE, Biltekin SN, Ak Sakallı E, Demirci B, et al. In Vitro and In Silico Evaluation of ACE2 and LOX Inhibitory Activity of Origanum Essential Oils and Carvacrol. Planta Medica. 2023;89(08):790-799. doi:10.1055/a-1828-2479

BibTeX
@article{Demirci2023,
  author = {Demirci, Fatih and Teralı, Kerem and Karadağ, Ayşe Esra and Biltekin, Sevde Nur and Ak Sakallı, Ezgi and Demirci, Betül and Koşar, Müberra and Başer, K Hüsnü Can},
  title = {In Vitro and In Silico Evaluation of ACE2 and LOX Inhibitory Activity of Origanum Essential Oils and Carvacrol},
  journal = {Planta Medica},
  year = {2023},
  volume = {89},
  number = {08},
  pages = {790--799},
  doi = {10.1055/a-1828-2479}
}
Kostenlos starten →